PATHWAY TO CURE

Continuing Education

Webinar Series for the Pathway to Cure Project

Navigation


Description

The webinar series will feature information about the purpose and implementation of the clinical pathways project and highlight the important topics relating to breast cancer care for young women. The goal of these pathways is to cue oncology care providers to internal and external resources, evidence, and open research studies to guide the treatment and support of young women diagnosed with breast cancer.

Co-PIs:
  • Elizabeth Reed, MD, Professor, Internal Medicine, Division of Oncology and Hematology & Robin M. Lally, PhD, RN, AOCN, FAAN, Professor, College of Nursing
Co-I:
  • Brenda Ram, CMP, CHCP, Interim Director, Center for Continuing Education

Target Audience

These webinars are intended for oncology care providers at UNMC and two collaborating rural cancer centers in Nebraska.


Requirements for Successful Completion:

In order to receive continuing education credit, you must

  1. Review the continuing education page on the website
  2. Review the entire webinar
  3. Complete the online evaluation
    • Go to unmc.edu/cce
    • Sign in to My Account
    • Choose Evaluate a course/Print Certificate
    • Use CME Activity Code 
    • Save and print your certificate. 

Certificates are available upon completion of the evaluation and attestation and up to 60 days post activity expiration date. Please retain for your records and future reference. 


Educational Objectives and Requirements for Successful Completion:

At the conclusion of the Decision Making webinar, the participant should be better able to:
  • Discuss treatment approaches for the care of young women with breast cancer
  • Describe cancer characteristics affecting decision making
At the conclusion of the Hereditary Breast Cancer webinar, the participant should be better able to:
  • Differentiate between sporadic and hereditary breast cancer, and identify the red flags of a hereditary breast cancer
  • Discuss hereditary breast cancer genes and the variability of associated cancers
  • Describe the complex considerations of genetic testing and the role and importance of a genetic counselor
  • Discuss the utility of the genetic testing results for medical management
At the conclusion of the Lymphedema webinar, the participant should be better able to:
  • Define lymphedema
  • Recognize signs and symptoms that correspond to stages of lymphedema
  • Describe symptom assessment for lymphedema and appropriate referral to a lymphedema specialist
  • Identify topics for lymphedema education for cancer survivors with or at risk for lymphedema
  • Discuss activity guidelines and principles of physical activity for survivors with or at risk for lymphedema
At the conclusion of the Psychosocial Distress in the Cancer Process webinar, the participant should be better able to:
  • Identify psychosocial issues to consider when caring for women under 50 years of age
  • Recognize prevention and intervention strategies used by behavioral health professionals in the care of women with breast cancer
  • Describe screening and triage services available in oncology
At the conclusion of the Survivorship webinar, the participant should be better able to:
  • Define cancer survivorship
  • Explain the importance of having a survivorship care plan
  • Discuss common health issues surrounding breast cancer survivors including late and long-term effects
  • List survivorship resources available to providers
At the conclusion of the Endocrine Therapy webinar, the participant should be better able:
  • Appreciate the benefits of adjuvant endocrine therapy in ER positive breast cancer in pre-menopausal women
  • Recognize the increased risk of relapse in very young women with ER positive breast cancer
  • Compare the various approaches for endocrine therapy and apply these to appropriate subsets of young patients with ER positive breast cancer
At the conclusion of the Contemporary Research Agenda in Exercise Oncology: New Paradigms for Promoting Activity Behaviors webinar, the participant should be able to:
  • Define the physical activity (PA) guidelines for cancer survivors
  • Identify benefits of PA for which for which we have the most and least evidence
  • Recognize resources for implementing the PA guidelines in clinical care
At the conclusion of the Radiation Oncology webinar, the participant should be better able to:
  • Compare various approaches of radiation oncology treatment in young women.
  • Recognize factors affecting the decision making with radiation treatment.
  • Discuss the decision making and partnering with other oncology professionals.
At the conclusion of the Reproductive/Sexual Wellness webinar, the participant should be better able to:
  • Recognize the importance of reproductive and sexual wellness consultation for women under 50.
  • Identify the areas of potential gynecologic concern, quality of life, and relationships.
  • Discuss considerations for family planning.
  • Describe how cancer treatment may affect sexuality, body image, and premature menopausal symptoms.

Release Date: 02/12/2020

Expiration Date: 02/01/2021


Estimated Time to Complete: 

Decision Making 30 minutes

Hereditary Breast Cancer 35 minutes

Lymphedema 13 minutes

Psychosocial Distress 10 minutes

Survivorship 45 minutes

Endocrine Therapy 30 min

Hereditary Breast Cancer 35 min

Contemporary Research Agenda in Exercise Oncology: New Paradigms for Promoting Activity Behaviors 20 minutes

Radiation Oncology 15 minutes

Reproductive/Sexual Wellness 15 minutes


Credit:

The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Decision Making Register here (Use Code 45102)

The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of .50 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hereditary Breast Cancer Register here (Use Code 41670)

The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of .50 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Lymphedema Register here (Use Code 45103)

The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of .25 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Psychosocial Distress  Register here (Use Code 45104)

The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of .25 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Survivorship Register here (Use Code 41671)

The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of .75 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Endocrine Therapy Register here (Use Code 41669)

The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of .50 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contemporary Research Agenda in Exercise Oncology: New Paradigms for Promoting Activity Behaviors  Register here(Use Code 45105)

The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of .25 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Radiation Oncology Register here (Use Code 45101)

The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of .25 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Reproductive/Sexual Wellness Register here (Use Code 45100)

The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of .25 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure

As a provider accredited by ACCME, the University of Nebraska Medical Center, Center for Continuing Education, must ensure balance, objectivity, independence, and scientific rigor in its educational activities. Faculty are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or the trade names of several to ensure impartiality.

All presenters, planners, and others in a position to control continuing medical education content participating in a University of Nebraska Medical Center, Center for Continuing Education activity are required to disclose relationships with commercial interests.  A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.  Disclosure of these commitments and/or relationships is included in activity materials so that participants in the activity may formulate their own judgments in interpreting its content and evaluating its recommendations.

This activity may include presentations in which presenters may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved.  Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications.

The following indicates the disclosure declaration information and the nature of those commercial relationships.


COURSE FACULTY AND PLANNING COMMITTEE DISCLOSURES

Faculty and planning committee members for this activity have no conflicts to disclose, with the exception of those listed below:

Elizabeth Reed, MD: Pfizer funded Principal Investigator on this grant.

Robin M. Lally, PhD, RN, AOCN, FAAN: Pfizer funded Co-Principal on this grant.

Sarah Thayer, MD, PhD: Scientific expert and advisory panel for DLA Piper, Exact Sciences & SPMB.


Disclaimers

The opinions or views expressed in this continuing education activity are those of the faculty and do not necessarily reflect the opinions or recommendations of the University of Nebraska Medical Center, Center for Continuing Education. Healthcare professionals and other individuals should review and consider other publications and materials on the subject before relying solely upon the information contained within this educational activity.


Presenters and Project Committee

Elizabeth Reed, MD, Professor, Internal Medicine, Division of Oncology and Hematology

Robin M. Lally, PhD, RN, AOCN, FAAN, Professor, College of Nursing

Brenda Ram, CMP, CHCP, Interim Director, Center for Continuing Education

Terri Blase, MS, LCGC

Diane Ehlers, PhD

Jennifer Griffin, MD, MPH

Adam Mills, PhD

Jacqueline Rauth Reisinger, MA, MPT, CLT

Rachael Schmidt, APRN-NP

Sarah Thayer, MD, PhD

Andrew Wahl, MD


Financial Support

Supported by a grant from Pfizer Inc. through a collaborative project with the NCCN Oncology Research Program.


© 2019 University of Nebraska Medical Center
Email: pathwaytocure@unmc.edu | University Computer Use Policy | Notice of Privacy Practices | Notice of Nondiscrimination | Comments